These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 30374347)

  • 1. Modulating Iron for Metabolic Support of TB Host Defense.
    Phelan JJ; Basdeo SA; Tazoll SC; McGivern S; Saborido JR; Keane J
    Front Immunol; 2018; 9():2296. PubMed ID: 30374347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desferrioxamine Supports Metabolic Function in Primary Human Macrophages Infected With
    Phelan JJ; McQuaid K; Kenny C; Gogan KM; Cox DJ; Basdeo SA; O'Leary S; Tazoll SC; Ó Maoldomhnaigh C; O'Sullivan MP; O'Neill LA; O'Sullivan MJ; Keane J
    Front Immunol; 2020; 11():836. PubMed ID: 32477344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host-Pathogen Interaction as a Novel Target for Host-Directed Therapies in Tuberculosis.
    Abreu R; Giri P; Quinn F
    Front Immunol; 2020; 11():1553. PubMed ID: 32849525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics of
    Hoffmann E; Machelart A; Song OR; Brodin P
    Front Immunol; 2018; 9():86. PubMed ID: 29441067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Molecular Inflammatory Pathways in Granuloma as Host-Directed Therapies for Tuberculosis.
    Guler R; Ozturk M; Sabeel S; Motaung B; Parihar SP; Thienemann F; Brombacher F
    Front Immunol; 2021; 12():733853. PubMed ID: 34745105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Tuberculosis Antimicrobials on the Immunometabolic Profiles of Primary Human Macrophages Stimulated with
    Cahill C; Cox DJ; O'Connell F; Basdeo SA; Gogan KM; Ó'Maoldomhnaigh C; O'Sullivan J; Keane J; Phelan JJ
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Interplay Between Autophagy and Immunometabolism for Host Defense Against Mycobacterial Infection.
    Paik S; Jo EK
    Front Immunol; 2020; 11():603951. PubMed ID: 33262773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The C-Type Lectin Receptor DC-SIGN Has an Anti-Inflammatory Role in Human M(IL-4) Macrophages in Response to
    Lugo-Villarino G; Troegeler A; Balboa L; Lastrucci C; Duval C; Mercier I; Bénard A; Capilla F; Al Saati T; Poincloux R; Kondova I; Verreck FAW; Cougoule C; Maridonneau-Parini I; Sasiain MDC; Neyrolles O
    Front Immunol; 2018; 9():1123. PubMed ID: 29946317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeutics.
    Hawn TR; Shah JA; Kalman D
    Immunol Rev; 2015 Mar; 264(1):344-62. PubMed ID: 25703571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunometabolism during Mycobacterium tuberculosis Infection.
    Howard NC; Khader SA
    Trends Microbiol; 2020 Oct; 28(10):832-850. PubMed ID: 32409147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting immunometabolism in host defence against Mycobacterium tuberculosis.
    Sheedy FJ; Divangahi M
    Immunology; 2021 Feb; 162(2):145-159. PubMed ID: 33020911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis.
    Boland R; Heemskerk MT; Forn-Cuní G; Korbee CJ; Walburg KV; Esselink JJ; Carvalho Dos Santos C; de Waal AM; van der Hoeven DCM; van der Sar E; de Ries AS; Xie J; Spaink HP; van der Vaart M; Haks MC; Meijer AH; Ottenhoff THM
    mBio; 2023 Feb; 14(1):e0302422. PubMed ID: 36475748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review.
    Kiran D; Podell BK; Chambers M; Basaraba RJ
    Semin Immunopathol; 2016 Mar; 38(2):167-83. PubMed ID: 26510950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Inhibition of Host Histone Deacetylases (HDACs) Enhances
    Moreira JD; Koch BEV; van Veen S; Walburg KV; Vrieling F; Mara Pinto Dabés Guimarães T; Meijer AH; Spaink HP; Ottenhoff THM; Haks MC; Heemskerk MT
    Front Immunol; 2020; 11():36. PubMed ID: 32117228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage defense mechanisms against intracellular bacteria.
    Weiss G; Schaible UE
    Immunol Rev; 2015 Mar; 264(1):182-203. PubMed ID: 25703560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into the evasion of host innate immunity by Mycobacterium tuberculosis.
    Chai Q; Wang L; Liu CH; Ge B
    Cell Mol Immunol; 2020 Sep; 17(9):901-913. PubMed ID: 32728204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host-Directed Therapeutics as a Novel Approach for Tuberculosis Treatment.
    Kim YR; Yang CS
    J Microbiol Biotechnol; 2017 Sep; 27(9):1549-1558. PubMed ID: 28683527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolically active neutrophils represent a permissive niche for Mycobacterium tuberculosis.
    Andrews JT; Zhang Z; Prasad GVRK; Huey F; Nazarova EV; Wang J; Ranaraja A; Weinkopff T; Li LX; Mu S; Birrer MJ; Huang SC; Zhang N; Argüello RJ; Philips JA; Mattila JT; Huang L
    Mucosal Immunol; 2024 Oct; 17(5):825-842. PubMed ID: 38844208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host defense mechanisms against Mycobacterium tuberculosis.
    Chai Q; Lu Z; Liu CH
    Cell Mol Life Sci; 2020 May; 77(10):1859-1878. PubMed ID: 31720742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approaches to tuberculosis--novel drugs based on drug targets related to toll-like receptors in macrophages.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4404-17. PubMed ID: 24245765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.